These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23276809)

  • 1. Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV.
    Jansson J; Wilson DP; Carr A; Petoumenos K; Boyd MA
    AIDS; 2013 May; 27(8):1245-51. PubMed ID: 23276809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada.
    Lima VD; Eyawo O; Ma H; Lourenço L; Chau W; Hogg RS; Montaner JS
    J Int AIDS Soc; 2015; 18(1):20261. PubMed ID: 26449273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis.
    Teeraananchai S; Kerr SJ; Amin J; Ruxrungtham K; Law MG
    HIV Med; 2017 Apr; 18(4):256-266. PubMed ID: 27578404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-AIDS Mortality Is Higher Among Successfully Treated People Living with HIV Compared with Matched HIV-Negative Control Persons: A 15-Year Follow-Up Cohort Study in Sweden.
    de Coninck Z; Hussain-Alkhateeb L; Bratt G; Ekström AM; Gisslén M; Petzold M; Svedhem V
    AIDS Patient Care STDS; 2018 Aug; 32(8):297-305. PubMed ID: 30067408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.
    Gueler A; Moser A; Calmy A; Günthard HF; Bernasconi E; Furrer H; Fux CA; Battegay M; Cavassini M; Vernazza P; Zwahlen M; Egger M;
    AIDS; 2017 Jan; 31(3):427-436. PubMed ID: 27831953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study.
    Rossetti B; Baldin G; Sterrantino G; Rusconi S; De Vito A; Giacometti A; Gagliardini R; Colafigli M; Capetti A; d'Ettorre G; Celani L; Lagi F; Ciccullo A; De Luca A; Di Giambenedetto S; Madeddu G
    Antiviral Res; 2019 Sep; 169():104552. PubMed ID: 31283942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and causes of death in people living with HIV in the era of combination antiretroviral therapy compared with the general population in Japan.
    Nishijima T; Inaba Y; Kawasaki Y; Tsukada K; Teruya K; Kikuchi Y; Gatanaga H; Oka S
    AIDS; 2020 May; 34(6):913-921. PubMed ID: 32039993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.
    May M; Gompels M; Delpech V; Porter K; Post F; Johnson M; Dunn D; Palfreeman A; Gilson R; Gazzard B; Hill T; Walsh J; Fisher M; Orkin C; Ainsworth J; Bansi L; Phillips A; Leen C; Nelson M; Anderson J; Sabin C
    BMJ; 2011 Oct; 343():d6016. PubMed ID: 21990260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment.
    Bor J; Herbst AJ; Newell ML; Bärnighausen T
    Science; 2013 Feb; 339(6122):961-5. PubMed ID: 23430655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Follow-Up Visits Among People Living With HIV: Results From the TREAT Asia and Australian HIV Observational Databases.
    Jiamsakul A; Boyd M; Choi JY; Edmiston N; Kumarasamy N; Hutchinson J; Law M; Ditangco R;
    J Acquir Immune Defic Syndr; 2021 Sep; 88(1):70-78. PubMed ID: 33990493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life expectancy after initiation of combination antiretroviral therapy in Thailand.
    Teeraananchai S; Chaivooth S; Kerr SJ; Bhakeecheep S; Avihingsanon A; Teeraratkul A; Sirinirund P; Law MG; Ruxrungtham K
    Antivir Ther; 2017; 22(5):393-402. PubMed ID: 28054931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Selected Outcomes of Combination Antiretroviral Therapy: Yemen Cohort Retrospective Descriptive Studies.
    Nabih MF; Puteh SEW; Nur AM
    Sci Rep; 2019 Dec; 9(1):19923. PubMed ID: 31882645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study.
    Hogg RS; Eyawo O; Collins AB; Zhang W; Jabbari S; Hull MW; Lima VD; Ahmed T; Kendall CE; Althoff KN; Justice AC; Barrios R; Shoveller J; Montaner JSG;
    Lancet HIV; 2017 Jun; 4(6):e270-e276. PubMed ID: 28262574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When to start antiretroviral therapy in resource-limited settings.
    Walensky RP; Wolf LL; Wood R; Fofana MO; Freedberg KA; Martinson NA; Paltiel AD; Anglaret X; Weinstein MC; Losina E;
    Ann Intern Med; 2009 Aug; 151(3):157-66. PubMed ID: 19620143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.
    Losina E; Schackman BR; Sadownik SN; Gebo KA; Walensky RP; Chiosi JJ; Weinstein MC; Hicks PL; Aaronson WH; Moore RD; Paltiel AD; Freedberg KA
    Clin Infect Dis; 2009 Nov; 49(10):1570-8. PubMed ID: 19845472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of early access to HIV services and starting cART in the UK 1996-2008.
    Beck EJ; Mandalia S; Sangha R; Sharott P; Youle M; Baily G; Brettle R; Gompels M; Johnson M; McCarron B; Ong E; Pozniak A; Schwenk A; Taylor S; Walsh J; Wilkins E; Williams I; Gazzard B;
    PLoS One; 2011; 6(12):e27830. PubMed ID: 22194795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.
    McManus H; O'Connor CC; Boyd M; Broom J; Russell D; Watson K; Roth N; Read PJ; Petoumenos K; Law MG;
    PLoS One; 2012; 7(11):e48839. PubMed ID: 23144991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.
    Freedberg KA; Kumarasamy N; Losina E; Cecelia AJ; Scott CA; Divi N; Flanigan TP; Lu Z; Weinstein MC; Wang B; Ganesh AK; Bender MA; Mayer KH; Walensky RP
    AIDS; 2007 Jul; 21 Suppl 4(Suppl 4):S117-28. PubMed ID: 17620747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study.
    Nsanzimana S; Remera E; Kanters S; Chan K; Forrest JI; Ford N; Condo J; Binagwaho A; Mills EJ
    Lancet Glob Health; 2015 Mar; 3(3):e169-77. PubMed ID: 25701995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
    Okomo U; Togun T; Oko F; Peterson K; Townend J; Peterson I; Jaye A
    BMC Pediatr; 2012 Jul; 12():95. PubMed ID: 22770231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.